Protagonist Therapeutics, Inc (PTGX)
NASDAQ · Manufacturing · Pharmaceutical preparations
PTGX price, last 12 months
Key stats
- Previous close
- $127.16
- Open
- $127.38
- Day range
- $123.67 – $128.89
- 52-week range
- $77.00 – $160.81
- Volume
- 554.2K
- Avg volume (20 days)
- 573.4K
- Market cap
- $8.5B
Performance
Technicals and fundamentals
About Protagonist Therapeutics, Inc
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $8.5B